| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2020 12-31 |
|---|---|---|---|
| Report Filing | 2025-11-10 | 2025-03-31 | 2021-03-25 |
| Revenue | 444.5 | 379.8 | 0 |
| Cost of Revenue | 281.8 | 260.2 | 0 |
| Gross Profit | 162.7 | 119.6 | 0 |
| Operating Expenses | 115.9 | 235.6 | 0.922 |
| Research & Development | 32.5 | 41.06 | 0 |
| Selling, General and Administrative | 33.23 | 58.91 | 0 |
| Other Operating Expenses | 50.22 | 135.7 | 0.922 |
| Operating Income | 46.72 | -116.1 | -0.922 |
| Net Non-Operating Interest | -4.49 | -8.97 | 0 |
| Interest Income | 0.802 | 0.742 | 0 |
| Interest Expense | 5.29 | 9.71 | 0 |
| Equity & Other Income/(Expense) | -169.4 | -70.4 | 2.66 |
| Income Before Tax | -127.1 | -195.5 | 1.74 |
| Income Tax Expense | 0.959 | 0 | 0.367 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 |
| Net Income | -128.1 | -195.5 | 1.38 |
| Depreciation and Amortization | 8.27 | 0 | 1.93 |
| EBITDA | 54.99 | -116.1 | 1.01 |
| Earnings Per Share (EPS) | -0.405 | -0.61 | 0.039 |
| Diluted Earnings Per Share | -0.545 | -0.61 | 0.039 |
| Weighted Average Shares Outstanding | 323.8 | 318,463 | 35.47 |
| Diluted Weighted Average Shares Outstanding | 323.8 | 318,463 | 35.47 |
